US Patent Issued to Regeneron Pharmaceuticals on March 18 for "Microchip capillary electrophoresis assays and reagents" (New York Inventors)

ALEXANDRIA, Va., March 19 -- United States Patent no. 12,253,490, issued on March 18, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Microchip capillary electrophoresis assays and reagents" was invented by Timothy Riehlman (East Greenbush, N.Y.), Gabriel Carreau (Troy, N.Y.), Jeffrey Schneiderheinze (Delmar, N.Y.) and Nicole M. Nall (Greenwich, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "MCE assays and reagents to assess purity and to identify impurities in protein drug product samples are provided. Methods for analyzing analytes in a protein drug sample are provided."

The patent was filed on June 1, 2021, under Application No. 17/335,756.

*For further information, including ima...